What are the key drivers of the significant revenue growth reported?

The substantial increase in total revenues, up 34% year-over-year, was primarily driven by a 35% surge in premium revenue, reaching $11.29 billion for the nine months ended September 30, 2003. This growth is attributed to strong membership increases, particularly in the National Accounts and Individual business segments, coupled with premium rate adjustments across various business lines.

Can you explain the significance of the announced merger with WellPoint Health Networks Inc.?

The announced merger with WellPoint Health Networks Inc. is a major strategic development, valued at approximately $16.4 billion. This transaction is expected to significantly expand Elevance Health's market presence and offerings, creating a larger, more diversified managed care organization. The merger is anticipated to close by mid-2004, pending regulatory and shareholder approvals.

How is the company managing the rising cost of care?

The company is actively managing the cost of care, which increased by approximately 10% for its fully-insured businesses. Key strategies include promoting performance-based contracts, developing clinical affiliations for evidence-based care, expanding relationships with medical societies, implementing contracting strategies with fixed rate fee schedules, and utilizing pharmacy cost management programs such as drug utilization review and formulary evaluation. These initiatives aim to balance cost containment with quality care.

What is the company's current financial health and liquidity position?

Elevance Health maintains a robust financial and liquidity position. As of September 30, 2003, the company held $7.2 billion in cash and investments. The consolidated debt-to-capital ratio stood at a healthy 22.1%, indicating a well-managed capital structure. The company expects its operating cash flows and available credit facilities to be sufficient to meet future obligations and strategic initiatives, including the WellPoint merger.

ELV 10-Q Quarterly Report Q3 FY2003 — Revenue, Net Income, EPS

Summary

Elevance Health, Inc. (ELV), formerly Anthem, Inc., reported strong financial performance for the nine months ended September 30, 2003, with net income increasing by 50% to $565.5 million compared to the prior year. Total revenues also saw a significant jump of 34% to $12.48 billion, driven by a substantial increase in premium revenue, up 35% to $11.29 billion. This growth reflects strong membership gains, particularly in National Accounts and Individual businesses, which increased total membership by 8% year-over-year. A major development announced during the quarter was the definitive agreement to merge with WellPoint Health Networks Inc., a transaction valued at approximately $16.4 billion. This strategic move, expected to close by mid-2004, signals a significant expansion for the company. The company also highlighted ongoing efforts to manage cost of care trends, which increased by approximately 10% for fully-insured Local Large Group and Small Group businesses, driven by professional and outpatient services costs. The company remains focused on strategic initiatives to control costs while expanding its market reach.

Key Highlights

1Net income increased by 50% to $565.5 million for the nine months ended September 30, 2003, compared to $377.2 million in the prior year.
2Total revenues grew by 34% to $12.48 billion for the nine months ended September 30, 2003, driven by a 35% increase in premium revenue.
3Total membership increased by 8% (895,000 members) year-over-year to 11.85 million, with notable growth in National Accounts and Individual segments.
4Announced a definitive agreement to merge with WellPoint Health Networks Inc. for approximately $16.4 billion, a significant strategic expansion expected to close by mid-2004.
5Cost of care for fully-insured Local Large Group and Small Group businesses increased by approximately 10%, driven by professional and outpatient services.
6Managed care administrative expenses increased by 31% to $2.27 billion for the nine months, reflecting business growth and integration costs.
7The company maintained a strong financial position with $7.2 billion in cash and investments as of September 30, 2003, and a consolidated debt-to-capital ratio of 22.1%.

Elevance Health, Inc. Quarterly Report for Q3 Ended Sep 30, 2003

Summary

Key Highlights

Frequently Asked Questions